Pain Threshold vs Tolerance: Why Pain Feels Different

Two people can face a similar stimulus and have very different experiences. Those differences deserve curiosity and care.

“I have a high pain threshold” often means “I can put up with a lot.” In pain research, those are different ideas. The distinction matters when someone’s symptoms are brushed aside because they look calm, keep working, or respond differently from another person.

In Charting the Brain’s Pain Map: Why Mine Is Different Than Yours, neuroscientist Karen Davis examines variation between people and within the same person over time. For Cindra, that raises a practical question: how do we offer support without turning a complex experience into a fixed label?

Pain threshold vs pain tolerance

The IASP terminology distinguishes the beginning of a painful experience from the amount of painful stimulation a person is willing to accept in a given situation. Both depend on the person’s experience. A number recorded by a testing device is not the experience itself.

Imagine a supervised research task where a stimulus changes gradually within an approved safety protocol. Saying “That has started to hurt” answers the threshold question. Saying “I want to stop” answers a different question. This example explains the terms; it is not an invitation to test your limits at home.

Someone might notice pain early and still continue with a demanding task. Another person may notice it later and choose to stop promptly. Neither response gives an observer a complete account of what that person feels.

Why do people feel pain differently?

Pain sensitivity reflects more than one influence. Tissue injury, inflammation, nerve function, sleep, attention, past experiences, and social circumstances can all matter. The NIH’s overview describes pain as an experience shaped by biological, psychological, and social factors. The mix differs between people and can change over time.

That makes comparisons such as “My injury was worse and I managed” poor guides to care. They compare visible circumstances while leaving much of the person’s experience out. Even a well-designed laboratory measure addresses a specific stimulus and setting, not everything about life with chronic pain.

What does the brain’s map add?

Davis’s account moves beyond identifying a single active spot. She asks how different systems work together and how those relationships change. Our illustrated guide to brain pain maps explains the imaging methods and their limits.

In their 2013 study, 51 healthy volunteers took part in research involving painful stimulation and reports of where their attention had been. The imaging work linked shifts of attention away from pain with changes involving the default mode network and PAG. It helped show why a static picture misses some of what the brain is doing.

The study did not test whether an app could relieve chronic pain. It also did not establish that people can simply choose to stop attending to pain. Its participants and experimental setting place limits on what we can infer about a person struggling through a flare at home.

Should increasing pain tolerance be the goal?

Not necessarily. The useful clinical question is what might help with your symptoms and daily life. Chasing a higher tolerance score can distract from that goal. In the webinar’s closing discussion, Davis presents the possibility of using research measures to guide treatment. She also acknowledges that the work was still experimental.

For a person seeking help now, a conversation about sleep, medication effects, activity demands, and treatment preferences can be more useful than a label such as “low tolerance.” A clinician can help decide which difficulties need assessment and what options fit. Our guide to multimodal pain management explains how different approaches can be coordinated.

Trying an attention exercise should be optional. You might find it helpful, neutral, frustrating, or tiring. An exercise that does not help is information about that exercise in your circumstances. It should not become a judgment about your effort.

Personalization for Cindra starts with listening

A useful companion should ask what would help today and allow the answer to change. For example, someone might want a short distraction one evening and help organizing questions for a clinician the next. These are hypothetical uses, not claims about deployed features.

We would apply Davis’s research through these proposed design requirements:

• Ask permission before an exercise. Offer an easy way to stop, skip, or choose a different kind of support. Avoid treating completion as evidence that pain is improving.
• Use observations without inventing causes. “You reported worse pain after three difficult nights” preserves the report. “Poor sleep caused your flare” adds a conclusion that the record cannot establish.
• Let people correct personalization. A preference for conversation over a body-focused exercise should remain editable. It should not become a permanent brain profile.
• Make symptom changes easy to raise. An existing chronic pain diagnosis should not cause the companion to dismiss new or worsening symptoms as familiar sensitivity. Escalation needs a clinically reviewed process.

That is our interpretation for product design. Demonstrating that Cindra provides these protections, or improves outcomes, would require implementation checks and product-specific evaluation.

Reading the webinar in context

Work Wellness Institute published this recording on December 13, 2016. Our review covered the full auto-generated English captions and selected slides, not continuous audiovisual viewing. The discussion of individual differences begins around 34:48; attention and changing connections appear around 42:30.

The Q&A adds a qualification worth keeping: some examples came from healthy volunteers, rather than people with chronic pain. A finding about a group should not be used to predict an individual’s response based on sex, personality, or a short chat.

Educational commentary and proposed product requirements. Sources checked October 27, 2026. This article has not undergone clinical review and does not provide an individualized care plan. Cindra requires product-specific evaluation before clinical benefit can be claimed.